Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Rheum Dis ; 20(10): 1337-1349, 2017 Oct.
Article in English | MEDLINE | ID: mdl-26481104

ABSTRACT

AIM: To investigate the antinociceptive, antiedematogenic and chondroprotective effects of diacerein (DIA) in a model of joint inflammation induced by complete Freund's adjuvant (CFA), as well as to investigate the involvement of metalloproteinase (MMP)-9, transient receptor potential vanilloid 1 (TRPV1) and glial cells in DIA's action mechanism. METHODS: Complete Freund's adjuvant was injected into the knee joint of male rats. We observed mechanical and cold hypersensitivity, vocalization and spontaneous pain-related behaviors, as well as edema of the knee. Tissue samples of the knee were stained with Cason`s technique and the thickness of the condilus cartilage was measured. Immunohistochemical analysis was performed on the spinal cord using anti-GFAP (glial fibrillary acidic protein), anti-MMP and anti-TRPV1 antibodies. Sections of the dorsal horns of the spinal cord were captured and an optical density was obtained. RESULTS: Complete Freund's adjuvant induced mechanical and thermal hypersensitivity, as well as joint edema and changes in the synovial membrane and cartilage. DIA (30 mg/kg, orally, daily) significantly inhibited mechanical (58 ± 10-87 ± 3%) and thermal (66 ± 12-87 ± 8%) hypersensitivity, vocalization (83 ± 5-41 ± 11%), spontaneous pain score, joint swelling (60 ± 6-40 ± 9%), as well as the histological changes induced by CFA. In addition, DIA inhibited astrocyte activation, and prevented the increase of MMP-9 and TRPV1 expression in the spinal cord of the animals subjected to CFA injections. CONCLUSIONS: In short, this study shows that DIA reduces joint damage and hypersensitivity associated with inflammation induced by CFA through the inhibition of astroglial activation and decreases the expression of TRPV1 and MMP-9 in the rat spinal cord.


Subject(s)
Analgesics/pharmacology , Anthraquinones/pharmacology , Antirheumatic Agents/pharmacology , Arthritis, Experimental/prevention & control , Behavior, Animal/drug effects , Joints/drug effects , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase Inhibitors/pharmacology , Neuroglia/drug effects , Spinal Cord/drug effects , TRPV Cation Channels/antagonists & inhibitors , Animals , Arthritis, Experimental/enzymology , Arthritis, Experimental/pathology , Arthritis, Experimental/psychology , Edema/enzymology , Edema/pathology , Edema/prevention & control , Freund's Adjuvant , Joints/pathology , Male , Neuroglia/enzymology , Neuroglia/pathology , Nociceptive Pain/chemically induced , Nociceptive Pain/enzymology , Nociceptive Pain/pathology , Nociceptive Pain/psychology , Rats, Wistar , Spinal Cord/enzymology , Spinal Cord/pathology , Spinal Cord/physiopathology , TRPV Cation Channels/metabolism , Thermosensing/drug effects , Time Factors , Vocalization, Animal/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...